Elwick Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -30.95%
(FY 2023)
- Profit -34.61%
(FY 2023)
- Ebitda 24.12%
(FY 2023)
- Net Worth 53.37%
(FY 2023)
- Total Assets 72.51%
(FY 2023)
About Elwick Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hardeep Nimber and Harpreet Nimber serve as directors at the Company.
- CIN/LLPIN
U24290CH2021PTC043452
- Company No.
043452
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2021
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Elwick Lifesciences Private Limited offer?
Elwick Lifesciences Private Limited offers a wide range of products and services, including Solar & Renewable Energy Products, Energy Conservation Equipment, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Antacid Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Elwick Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardeep Nimber  | Director | 14-Jan-2021 | Current |
| Harpreet Nimber | Director | 14-Jan-2021 | Current |
Financial Performance of Elwick Lifesciences.
Elwick Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.95% decrease. The company also saw a substantial fall in profitability, with a 34.61% decrease in profit. The company's net worth Soared by an impressive increase of 53.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elwick Lifesciences?
Unlock access to Elwick Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
N.N Remedies Private LimitedActive 6 years 8 monthsHardeep Nimber and Harpreet Nimber are mutual person
Acosta Derma Care Private LimitedActive 3 years 9 monthsHardeep Nimber and Harpreet Nimber are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elwick Lifesciences?
Elwick Lifesciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elwick Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elwick Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
